A Reflection on Friedreich’s Ataxia and Research from Sam Dupre
Community
News|Jun 29 2026
Press Release: Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia